Command Palette

Search for a command to run...

Clinical Trials · NCT01511692

Effect of Liraglutide Compared to Glimepiride on Appetite in Subjects With Type 2 Diabetes

CompletedPhase 1Liraglutide (Approved)
Phase
Phase 1
Recruitment status
Completed
Sponsor
Novo Nordisk A/S
Enrollment
43
Start date
Nov 2005
Locations
2 sites, Australia, Germany
Primary endpoint
The energy intake at a standardised buffet meal with a preload paradigm quantified using Foodworks 2.10
View Liraglutide compound reference